Martingale Asset Management’s German American Bancorp GABC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,000
Closed -$308K 787
2025
Q2
$308K Sell
8,000
-4,500
-36% -$169K 0.01% 696
2025
Q1
$469K Hold
12,500
0.01% 609
2024
Q4
$503K Hold
12,500
0.01% 605
2024
Q3
$484K Buy
+12,500
New +$480K 0.01% 630
2023
Q2
Sell
-6,708
Closed -$224K 832
2023
Q1
$224K Buy
6,708
+5
+0.1% +$186 ﹤0.01% 760
2022
Q4
$250K Buy
+6,703
New +$255K ﹤0.01% 751
2021
Q4
Sell
-6,000
Closed -$232K 844
2021
Q3
$232K Sell
6,000
-1,100
-15% -$40.9K ﹤0.01% 794
2021
Q2
$265K Hold
7,100
﹤0.01% 741
2021
Q1
$329K Buy
7,100
+1,000
+16% +$39.4K ﹤0.01% 725
2020
Q4
$202K Buy
+6,100
New +$193K ﹤0.01% 837
2016
Q1
Sell
-16,353
Closed -$364K 826
2015
Q4
$364K Sell
16,353
-13,650
-45% -$294K 0.01% 719
2015
Q3
$587K Buy
30,003
+13,345
+80% +$261K 0.01% 619
2015
Q2
$328K Buy
16,658
+375
+2% +$7.3K 0.01% 758
2015
Q1
$321K Buy
+16,283
New +$313K 0.01% 778

Other funds holding GABC

Martingale Asset Management's GABC Position: Q3 2025 in Review

Martingale Asset Management sold out of German American Bancorp (GABC) in Q3 2025, closing a stake of 8,000 shares — an estimated $308K sold.

Martingale Asset Management first reported a position in GABC in Q1 2015 and held it in 14 quarters. The position peaked at $587K in Q3 2015. 173 funds tracked by Wall St. Rank hold GABC as of Q3 2025.

  • Martingale Asset Management reported no remaining German American Bancorp position as of Q3 2025 after selling out during the quarter.
  • Martingale Asset Management sold 8,000 German American Bancorp shares in Q3 2025, an estimated $308K.
  • Martingale Asset Management first reported a position in German American Bancorp in Q1 2015 and held it in 14 quarters.
  • Martingale Asset Management's German American Bancorp position peaked at $587K in Q3 2015.
  • 173 funds tracked by Wall St. Rank held German American Bancorp as of Q3 2025.

Based on Martingale Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.